Behavioral Therapy Development for Methamphetamine Abuse

Stopped early · Phase 1

Conditions studied: Depression, Drug Abuse, Sexually Transmitted Diseases

In brief

The purpose of this study is to evaluate whether a specially developed group counseling approach is better able to help HIV-positive gay and bisexual men (GBM) who use crystal meth to stop using methamphetamines, reduce sexual risk behaviors, and stay on their HIV medications than a standard drug treatment program. Another purpose is to determine whether having a drug abuse treatment program in an HIV medical clinic makes it easier to attend treatment than going to a separate location for drug abuse treatment.

Key facts

Study ID

NCT00252434

Run by

University of California, Los Angeles

Starts

2004-08-01

Expected to finish

2007-11-01

Last updated by the study team

2016-01-27

Who can join

Age: 18 and older, up to 65. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• HIV-seropositive, GBM receiving medical treatment for HIV for at least 30 days prior to signing informed consent at the University of California, Los Angeles (UCLA) Center for Clinical AIDS Research and Education (CARE) clinic, aged 18-65
• Willing to give informed consent and comply with study procedures
• Willing to provide consent to contact treating physicians and pharmacies to assess adherence to HIV medications
• Diagnosed with current methamphetamine abuse as determined by Mini-International Neuropsychiatric Interview (MINI)
• Interested in seeking treatment for methamphetamine abuse and in participating in this research project.

You may not qualify if…

• Unwilling to give, or withdrawal of, informed consent
• Inability to understand nature of study
• A psychiatric condition that, in the principal investigator's judgment, warrants additional intervention to ensure participant safety (e.g., meets Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision [DSM-IV-TR] criteria for current bipolar disorder or a psychotic disorder)
• Current suicidal ideation or suicide attempt within the past 3 months
• Concurrent dependence on opiates, alcohol, or benzodiazepines as determined by MINI.
• Total lack of any type of healthcare coverage. These potential participants will be given low-fee treatment referrals.

Where it is running

• UCLA Center for Clinical AIDS Research and Education (CARE) Clinic — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.